Clinical Trials Arena· GlobalData Healthcare·· 22 小时前AI 评分20
IDWeek 2026：新型抗真菌药 turletricin 公布 II 期积极结果
IDWeek 2026: novel antifungal turletricin demonstrates positive Phase II results
AI 导读
在 IDWeek 2026 上，新型抗真菌药 turletricin 的 II 期试验结果呈积极。该结果在会议上公布，具体疗效与安全性数据未在正文中披露。
正文 · 原文
Unlock FREE Access to Premium Content
Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation.
With a free Clinical Trials Arena profile, you can:
- Access exclusive analyst commentary and expert insights
- View premium forecasts and data-driven clinical trial intelligence
- Stay up to date with clinical trial news, regulatory updates, and industry trends
- Receive alerts when new premium content is published
Unlock free access
Already have an account? Login here
Powered by
来源：Clinical Trials Arena · clinicaltrialsarena.com